Basic Nimotop Information

• INN (International Nonproprietary Name): Nimodipine
• Brand Names Available In United Kingdom: Nimotop (Bayer) and generic nimodipine formulations
• ATC Code: C08CA06
• Forms & Dosages: 30 mg soft gelatin capsules; oral liquids 30 mg/10 mL, 60 mg/10 mL and 60 mg/20 mL
• Manufacturers In United Kingdom: Bayer AG (original brand Nimotop); generics supplied by multiple manufacturers
• Registration Status In United Kingdom: Registered and used in hospital neurosurgical pathways
• OTC / Rx Classification: Prescription only (Rx)

Important notes for everyday life: Nimotop (nimodipine) is prescription-only in the United Kingdom and is used under hospital or GP direction.

Only take nimodipine after a neurosurgeon, stroke team or GP advises it, and never accept intravenous administration — IV use is contraindicated and can be fatal.

Store capsules and liquid below 25°C and keep them out of reach of children.

If you take other medicines, especially strong CYP3A4 inhibitors, check with a pharmacist before starting nimodipine.

Report any suspected side effects to the MHRA Yellow Card scheme.

Everyday Use & Best Practices

Morning Vs Evening Dosing

People ask whether nimodipine should be taken in the morning or evening when discharged from hospital.

The standard regimen is 60 mg every four hours for 21 days, which means doses fall throughout day and night rather than a simple morning/evening split.

Start within 96 hours after aneurysmal subarachnoid haemorrhage as advised by your neurosurgical team.

Use alarms, phone reminders or a hospital medication kardex to keep a strict four‑hour spacing, including overnight doses.

If carers or community nurses help, request a written dosing schedule on discharge to avoid missed doses.

Taking With Or Without Meals (UK Diet Habits)

Nimodipine may be taken with or without food, so fit dosing into typical UK meal patterns like hearty breakfasts and tea breaks.

Setting fixed times tied to meals can make adherence easier but should not replace the four‑hour schedule.

Capsules should be swallowed whole; if swallowing is difficult, ask for the oral liquid formulation which is suitable for oral or nasogastric administration.

Note that some oral solutions contain alcohol, so discuss alternatives with your pharmacist if you have alcohol-related problems.

• Checklist For A Dosing Plan: alarm times, written schedule for carers, liquid formulation available if required.
• Missed Dose Actions: take as soon as remembered unless the next dose is near; do not double up; contact clinician if multiple doses missed.

Safety Priorities

Who Should Avoid It (MHRA Warnings)

Known hypersensitivity to nimodipine or any excipient is an absolute contraindication.

Patients in severe hypotension or shock must not receive nimodipine because of risk of further cardiovascular collapse.

Concomitant prescription of strong CYP3A4 inhibitors such as some azole antifungals and macrolide antibiotics is contraindicated because raised nimodipine levels can cause profound hypotension.

Caution is required in moderate hepatic impairment due to increased bioavailability that may need dose adjustment and close monitoring.

Pregnancy and breastfeeding are precautionary situations; nimodipine should only be used if benefits outweigh risks under clinician supervision.

Activities To Limit (Driving, Work Safety)

Nimodipine commonly causes dizziness, light‑headedness or fainting due to hypotension, so avoid driving and operating heavy machinery until stable.

Do not return to safety‑critical work until a clinician confirms blood pressure and symptoms are stable.

Hospital staff will usually test orthostatic blood pressure and advise on safe mobilisation before discharge.

Ask friends or family to supervise early mobilisation at home, especially during the first few days after discharge.

• Contraindications Checklist: hypersensitivity, severe hypotension/shock, strong CYP3A4 inhibitors.
• Drugs To Avoid: list potential CYP3A4 inhibitors with your pharmacist before starting.

Dosage & Adjustments

General Regimen (NHS Guidance)

The standard adult dose after aneurysmal subarachnoid haemorrhage is 60 mg orally every four hours for 21 consecutive days started within 96 hours.

Oral liquids are typically 30 mg/10 mL or 60 mg/10 mL and are used for patients who cannot swallow capsules or require nasogastric administration.

Missed doses should be taken as soon as remembered unless the next scheduled dose is imminent; do not double-dose.

Overdose presents with severe hypotension and bradycardia and requires immediate supportive care and monitoring of vital signs.

Special Cases (Elderly, Comorbidities)

Children: safety and efficacy have not been established, so use is generally not recommended for paediatric patients.

Elderly: the usual adult dose is generally used but monitor carefully for hypotension and bradycardia due to increased sensitivity.

Liver impairment: consider dose reduction and closer blood pressure monitoring because nimodipine bioavailability increases in hepatic dysfunction.

Renal impairment: no specific adjustment is documented but clinical monitoring is advised.

• Monitoring Checklist: blood pressure, heart rate, signs of hypotension, gastrointestinal tolerance.

User Testimonials

Positive Reports From UK Patients

“I was relieved nimotop was started on the ward — the team explained how it helps reduce the risk of delayed strokes.”

Many UK patients report reassurance that a specific cerebral calcium‑channel blocker is given after an aneurysmal subarachnoid haemorrhage.

Positive comments on forums and Patient.info highlight clear nursing administration and trust in community pharmacists at Boots and LloydsPharmacy for discharge counselling and supply of nimodipine.

Carers often describe feeling comforted by a written dosing chart and the ward giving a first supply of capsules before discharge.

Common Challenges (Patient.info, NHS Forums)

Maintaining the strict four‑hourly dosing schedule at home, especially overnight, is the most frequent practical difficulty reported by patients.

Other common issues include light‑headedness, nausea and trouble swallowing capsules; several users requested liquid formulations or NG tube administration in hospital.

Some patients mention local pharmacy stock problems and worries about interactions when antibiotics or antifungals are prescribed after discharge.

• “How will I keep up at night?” — set alarms and ask carers for help.
• “I couldn’t find the liquid at my local pharmacy” — check availability ahead with your pharmacist.

Buying Guide

Pharmacy Sources (Boots, LloydsPharmacy, Superdrug)

Nimotop and generic nimodipine are prescription-only in the UK and hospital inpatients normally receive their supply on the ward.

Discharged patients require a valid prescription from a GP or hospital outpatient clinic to collect from community pharmacies such as Boots, LloydsPharmacy or Superdrug.

Liquid formulations may be stocked centrally in hospitals and should be requested from community pharmacies in advance to avoid delays.

In our online pharmacy, nimotop is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Price Comparison (NHS Prescription Charge Vs Private)

Within the NHS prescribing framework, patients in England usually pay the standard prescription charge per item unless exempt; Scotland, Wales and Northern Ireland have free prescriptions in most cases.

Private prescriptions vary in price between pharmacies and online suppliers, with generics generally less expensive than branded Nimotop.

Always ask your pharmacist about generic options and request a printout detailing availability and likely costs.

What’s Inside & How It Works

Ingredients Overview

The active substance is nimodipine (INN) sold as Nimotop or generic nimodipine.

The common UK packaged form is Nimotop 30 mg soft gelatin capsules in blister packs or tubs supplied by Bayer and subsidiaries.

Oral liquid formulations of 30 mg/10 mL and 60 mg/10 mL are available for those unable to swallow capsules and for nasogastric administration.

Excipients vary by manufacturer and some liquid products contain alcohol; always check the product label and SmPC if alcohol is a concern.

Mechanism Basics Explained Simply

Nimodipine is an L‑type dihydropyridine calcium channel blocker with cerebral selectivity (ATC C08CA06).

It relaxes cerebral vascular smooth muscle to reduce vasospasm after subarachnoid haemorrhage and thereby lowers the risk of delayed cerebral ischaemia.

Nimodipine’s benefit in this setting comes from targeted action on cerebral vessels rather than systemic blood pressure control alone.

Common side effects include hypotension, headache, nausea, bradycardia and peripheral oedema; these should be monitored by the treating team.

• Active Vs Excipients: nimodipine is the active ingredient; check labels for alcohol in liquids.
• How It Works: blocks calcium entry to relax cerebral arteries and reduce vasospasm risk.

Main Indications

Approved Uses (MHRA Listing)

Nimodipine is used and MHRA-listed for prevention and treatment of neurological deficits after aneurysmal subarachnoid haemorrhage.

The evidence-based standard regimen is oral 60 mg every 4 hours for 21 days started within 96 hours of the haemorrhage.

This indication is reflected in neurosurgical practice and hospital pathways across the UK and Europe.

Off-Label Uses In UK Clinics

There are occasional cautious off‑label uses in specific neurological situations, but no widely accepted alternative approved indication exists in the UK.

Other calcium channel blockers used for hypertension such as amlodipine or nifedipine are not approved substitutes for post‑SAH vasospasm prevention.

Any off‑label prescribing should be discussed with the treating clinician, documented in the notes and supported by local governance procedures.

• Approved Uses: prevention/treatment of post‑SAH neurological deficits.
• Off-Label Checklist: discuss risks/benefits, document justification, seek specialist input.

Interaction Warnings

Food Interactions (Alcohol, Tea/Coffee)

Some oral solutions contain alcohol so avoid or discuss with your pharmacist if you have alcohol dependence or are pregnant.

Normal tea and coffee intake do not have specific contraindications with nimodipine, but caffeine can worsen headaches or palpitations in some patients.

If any new symptoms occur after caffeine or alcohol, report them to your treating clinician or pharmacist for assessment.

Drug Conflicts (MHRA Yellow Card Reports)

Nimodipine is metabolised by CYP3A4, so strong CYP3A4 inhibitors such as ketoconazole, itraconazole and clarithromycin can raise nimodipine levels and may precipitate severe hypotension.

Concomitant use with other hypotensive drugs increases the risk of low blood pressure; clinicians and pharmacists should review the full medication list before discharge.

Report suspected interactions or serious adverse reactions via the MHRA Yellow Card scheme so regulators and clinicians can track safety signals.

Latest Evidence & Insights

Key UK & EU Studies 2022–2025

Audit data and systematic reviews through 2022–2024 continue to support oral nimodipine 60 mg every 4 hours for 21 days as standard care after aneurysmal SAH to reduce delayed cerebral ischaemic deficits.

Ongoing research is exploring optimised delivery methods, pharmacokinetics in hepatic impairment and approaches for refractory vasospasm, but no accepted substitute has emerged.

Local neurosurgical and hospital guidelines tend to reference the MHRA SmPC and established neurosurgical protocols when advising treatment and monitoring.

Practical Takeaways For Patients

Early initiation within 96 hours is important, and expect regular blood pressure monitoring while on nimodipine.

Ask about drug interaction checks, availability of liquid formulations if swallowing is a problem, and obtain a clear dosing chart before discharge.

If discharged, ensure you have contact details for your GP or community stroke team and understand when to seek help for worrying symptoms.

• Key Points: start early, monitor BP, check interactions, secure liquid formulation if needed.

Alternative Choices

NHS Prescribing Alternatives With Pros/Cons Checklist

There is no direct NHS alternative to nimodipine for prevention of cerebral vasospasm after SAH.

Other dihydropyridine calcium channel blockers such as amlodipine and nifedipine are indicated for hypertension but are not approved for post‑SAH vasospasm prevention.

Alternative management focuses on endovascular therapies like angioplasty or intra‑arterial vasodilators, haemodynamic augmentation and supportive neurocritical care.

• Nimodipine: proven for SAH, oral or NG administration, strict dosing schedule, hypotension risk.
• Amlodipine/Nifedipine: useful for BP control, not evidence‑based for SAH prevention.

When Nimotop Is Preferred

Nimotop is preferred for any patient with aneurysmal SAH when delayed cerebral ischaemia is a concern and oral or nasogastric administration is possible.

Multidisciplinary teams decide whether to combine nimodipine with endovascular interventions for refractory vasospasm on a case‑by‑case basis.

Discuss options with your neurosurgeon or stroke team if there is concern about hypotension or drug interactions.

Regulation Snapshot

MHRA Approval & NHS Prescribing Framework

Nimodipine (Nimotop and generics) is MHRA‑regulated and prescription‑only in the UK and forms part of standard neurosurgical pathways for SAH management.

Hospital trusts and NHS formularies list nimodipine with the SmPC guidance detailing dosing, contraindications and monitoring requirements.

Initiation commonly occurs in hospital under specialist teams, with GP or outpatient follow‑up to complete the treatment course if appropriate.

How To Verify SmPC & Yellow Card

Consult the product SmPC via the electronic Medicines Compendium or MHRA website for manufacturer‑specific details; Nimotop is manufactured by Bayer AG while generics vary.

Use the MHRA Yellow Card scheme to report side effects or suspected interactions so regulators can track safety information.

For supply or registration queries, ask your hospital pharmacy or community pharmacist to check national drug databases.

FAQ Section

Common UK Patient Questions

• Can I take nimotop at home? Yes, if you are discharged with a clear prescription, dosing schedule and follow‑up arranged with your GP or stroke team.
• Is nimotop available without prescription? No — Nimotop is prescription‑only in the UK; hospital supplies cover inpatients and community pharmacies require a valid prescription.
• What should I do about missed doses? Take the missed dose as soon as you remember unless the next dose is near; do not double up and contact your clinician if several doses are missed.
• Can I mix it with alcohol or take it with other medicines? Avoid alcohol if your oral solution contains alcohol and discuss all medicines with your pharmacist, especially antifungals or macrolide antibiotics which inhibit CYP3A4.

For further reading, see Patient.info and NHS pages on subarachnoid haemorrhage and post‑SAH care.

Guidelines For Proper Use

UK Pharmacist Counselling Style

Pharmacists should confirm the indication (post‑SAH), review the full medication list for CYP3A4 inhibitors and explain the 60 mg every 4 hours for 21 days regimen.

Show how to use liquid formulations and a dosing syringe if required, warn about hypotension symptoms and advise against driving until stable.

Explain storage needs (<25°C) and safe keeping away from children, provide Yellow Card reporting information and offer a printed dosing chart.

NHS Patient Support Advice

Arrange GP follow‑up or community stroke nurse review before discharge and ensure prescriptions are issued with pharmacy stock checked in advance.

If side effects occur, contact NHS 111, your GP or the neurosurgical team; attend A&E for severe reactions such as fainting or very low blood pressure.

Keep the SmPC or treatment card with you for appointments and carry contact details for your neurosurgical team or community stroke service.

• Printable Checklist For Patients And Carers: dosing chart, alarm plan, pharmacist contact, GP/stroke team details, Yellow Card link.

Delivery Across United Kingdom